BASF is merging two of its Swiss group companies: BASF Orgamol Pharma Solutions SA, Evionnaz, and BASF Fine Chemicals Switzerland SA, Evionnaz, into a single organisation. The company arising from the merger is called BASF Pharma (Evionnaz) SA and is based in Evionnaz, Switzerland.
President of the new organisation is Martin Widmann, general manager of the former BASF Fine Chemicals Switzerland and head of the BASF Pharma Ingredients & Services Business Unit. ‘The merger reduces complexity at our site and simplifies processes,’ Widmann said. ‘The two companies have been working closely together for many years.’ Managing director of BASF Pharma (Evionnaz) will be Dr Folker Ruchatz, former head of BASF Orgamol Pharma Solutions.
BASF Orgamol Pharma Solutions in Evionnaz, Switzerland and its sister company, BASF Orgamol Pharma Solutions France in Saint-Vulbas, France, were uniformly renamed BASF Pharma at the end of April 2010. ‘The renaming of both companies is part of our strategy of becoming more customer-centric as a supplier and partner to the pharmaceutical industry,’ Widmann stated. ‘It shows our clear commitment to the pharmaceutical industry and enhances our market visibility.’
Existing contracts with employees, suppliers and customers will be transferred unchanged to BASF Pharma (Evionnaz), and there will be no change in the number of employees.